Food and Drug Administration (FDA) Blogs This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

FTC Again Polices FDA's Laziness With Improper Orange Book Listings for Diabetes, Weight Loss, Asthma and COPD Drugs
Today (April 30, 2024), the U.S. Federal Trade Commission (FTC) announced that it had expanded its campaign against pharmaceutical manufacturers ’ improper or inaccurate listing of patents in the Food and Drug Administration ' s (FDA) Orange Book (see the news release athttps://www.ftc.gov/news-events/news/press-releases/2024/04/ftc-expands-patent-listing-challenges-targeting-more-300-junk-listings-diabetes-weight-loss-asthma for more information). FTC is targeting what it describes as more than 300 " junk " patent listings because the particular patents are legally ineligible to even be listed in the FDA Orange Book.Lis...
Source: Scott's Web Log - May 1, 2024 Category: Endocrinology Tags: 2024 FDA FTC improper listings Orange Book pharma Source Type: blogs

Ozempic And Other Weight Loss Drugs Will Only Work With Digital Health
Weight loss injections are now widely used as miracle drugs for effortless skinniness. But without digital health, they just won’t work in the long run. The U.S. Food and Drug Administration, the FDA, approved Wegovy, a semaglutide injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition for use in addition to a reduced calorie diet and increased physical activity in 2021. Semaglutide was originally used for the treatment of type 2 diabetes, and was found to have a major lucky side effect: being very effective in assisting weight loss. Semaglutide inject...
Source: The Medical Futurist - April 23, 2024 Category: Information Technology Authors: Andrea Koncz Tags: Digital Health Research weight management weight loss Ozempic Wagevy Source Type: blogs

Harnessing Digital Innovation to Unlock Cancer Discoveries
By DOUG MIRSKY & BRIAN GONZALEZ What if digital innovations could be the key to reducing the burden of cancer? CancerX was founded in 2023 as part of the Cancer Moonshot to achieve this goal. By uniting leading minds across industries such as technology, healthcare, science, and government, we are breaking down silos and leveraging digital innovation in the fight against cancer. With ambitious goals to cut the death rate from cancer by at least 50% and to improve the experience of people who are affected by cancer, digital innovation is critical. As a public-private partnership co-hosted by Moffitt Cancer Center ...
Source: The Health Care Blog - April 19, 2024 Category: Consumer Health News Authors: matthew holt Tags: Health Policy Health Tech Brian Gonzalez CancerX Digital Medicine Society Doug Mirsky Moffitt Cancer Center Source Type: blogs

Lilly's Carelessness in Discontinuing 3 mL vials of Humalog Causes Shortages in 10 mL vials of Humalog + Unbranded Lispro
Last week, the JDRF shared newshttps://x.com/JDRF/status/1770848177354137650 in a series of three Tweets about how Eli Lilly& Company, Inc. was reporting that 10 mL vials of Humalog and the company ' s identical, unbranded (meaning Lilly sells it using the generic drug name rather than brand-name Humalog) version of Humalog known as Lilly Insulin Lispro Injection could be facing temporary lack of availability in selected locations around the country. Lilly tried to reassure everyone that it was only a temporary issue. But while Lilly complains it cannot keep up with demand for Mounjaro/Zepbound, it is having its own su...
Source: Scott's Web Log - April 9, 2024 Category: Endocrinology Tags: Eli Lilly and Company 2024 Humalog lispro vials Source Type: blogs

Overjet Raises $53 Million: The Largest Investment in the History of Dental AI
With this Series C Funding, Overjet will Expand its AI Platform to Create the First Unified Standard for Dental Providers and Payers — Allowing Them to Give Patients the Best Possible Care Overjet, the world leader in dental AI, today announced a $53.2 million Series C round: the largest investment ever in artificial intelligence for dentistry. The historic round was led by March Capital, with participation from General Catalyst, Insight Partners, E14 Fund, Crosslink Capital, Spring Rock Capital, Liquid 2 Ventures, and Harmonic Growth Partners, as well as the American Dental Association. It brings Overjet’s total ...
Source: EMR and HIPAA - March 29, 2024 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT Aligned Dental Partners American Dental Association Crosslink Capital E14 Fund General Catalyst Harmonic Growth Partners Health IT Funding Health IT Fundings Health IT Investment Insight Partners Liq Source Type: blogs

Unlearn Raises $50 Million Series C to Optimize Clinical Research With AI-Powered Digital Twin Technology
Using Novel Digital Twins of Clinical Trial Participants, Unlearn is Accelerating Clinical Research to Help Bring New Treatments to Patients Sooner Unlearn, an AI company creating digital twins of clinical trial participants that enable smaller, faster studies, today announced a $50M Series C round led by Altimeter Capital, joined by returning investors Radical Ventures, Wittington Ventures, Mubadala Capital, Epic Ventures, and Necessary Venture Capital. This round of funding was secured to propel the company’s mission to advance AI to eliminate trial and error in medicine by investing in its people, data, engineering ca...
Source: EMR and HIPAA - February 29, 2024 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT 8VC Altimeter Capital Charles Fisher DCVC DCVC Bio Epic Ventures Health IT Funding Health IT Fundings Health IT Investment Insight Partners Mubadala Capital Necessary Venture Capital Pauline Yang Source Type: blogs

Rune Labs Unveils $12 Million Strategic Round to Accelerate Adoption of Novel Parkinson ’s Technologies
Brings Total Raised to Over $42 Million Co-Founder of Nexus NeuroTech and Former Verily President of Medical Devices Jordi Parramon Joins as New Board Member Rune Labs, a precision neurology software and data company, today announced a strategic round of $12 million, increasing the total amount raised by the company to over $42 million. The round was led by new brain disorder fund, Nexus NeuroTech Ventures, with participation from existing investors, including Eclipse, DigiTx Partners, Moment Ventures, and TruVenturo GmbH. Jordi Parramon, PhD, CEO, General Partner, and Co-Founder of Nexus NeuroTech Ventures and former Pre...
Source: EMR and HIPAA - February 6, 2024 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT Aspen Neuroscience Benjamin Stecher BlueRock Therapeutics Brian Pepin DigiTx Partners Eclipse Health IT Funding Health IT Fundings Health IT Investment Jordi Parramon Moment Ventures Nexus NeuroTec Source Type: blogs

Drug prices continued: Innovation?
Pharmaceutical manufacturers claim that they need patent protection and marketing exclusivity so they can charge high prices to recoup the costs of drug development and clinical trials. There are a few things wrong with this argument, but they add up to the general fact that the system does not serve the public interest. Drug companies care about one thing only, that is profit. And the pursuit of profit does not serve the interests of public health or social welfare.One obvious mismatch between the goal of public health and the goal of profit is that a relatively cheap drug that you can take once or for a week or so, that ...
Source: Stayin' Alive - January 23, 2024 Category: American Health Source Type: blogs

Best Of CES Health Tech 2024: From Medical Tricorders To AI-Powered Mirrors
The biggest tech event of the year, the Consumer Electronics Show (CES 2024) is happening right now in Vegas! This is the global stage where cutting-edge technologies and innovations debut year after year. From vehicles to smart homes, from robots to food tech all industries are present, but we keep our focus on our topic and introduce the most exciting novelties from the digital health – future of medicine field. 1. The medical tricorder from Withings Withings introduced a device that seems to leap out of a Star Trek episode. Their latest invention, the aptly named BeamO, is a 4 in 1 health monitor. While it i...
Source: The Medical Futurist - January 11, 2024 Category: Information Technology Authors: Andrea Koncz Tags: TMF CES 2024 Source Type: blogs

Biorithm Secures $3.5 Million in Series A Funding to Advance Maternal Care Worldwide
New Funds to Fortify US Market Entry and Growth Strategy, as well as Advance Breakthrough Research Biorithm, a global women’s health medtech, has closed $3.5 million in Series A funding, co-led by Adaptive Capital Partners and SEEDS Capital. With a homegrown spirit and a global vision, Biorithm is dedicated to developing cutting-edge solutions for personalized connected maternity care. The funding will fuel Biorithm’s expansion in Southeast Asia and the United States. It also will assist the company in advancing Femom, a comprehensive obstetric remote monitoring solution, and completing clinical studies to support ...
Source: EMR and HIPAA - December 27, 2023 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT Adaptive Capital Partners Amrish Nair Biorithm Health IT Funding Health IT Fundings Health IT Investment Julian Robinson SEEDS Capital Shi Ying Tan Kaixin Source Type: blogs

Science Snippet: Zooming In on Nanoparticles
Nanoparticles come in many different shapes and configurations. Credit: Adapted from Stevens, et. al., under Creative Commons License 4.0. Nanoparticles may sound like gadgets from a science fiction movie, but they exist in real life. They’re particles of any material that are less than 100 nanometers (one-billionth of a meter) in all dimensions. Nanoparticles appear in nature, and humans have, mostly unknowingly, used them since ancient times. For example, hair dyeing in ancient Egypt involved lead sulfite nanoparticles, and artisans in the Middle Ages added gold and silver nanoparticles to stained-glass windows. Over...
Source: Biomedical Beat Blog - National Institute of General Medical Sciences - December 13, 2023 Category: Research Authors: Chrissa Chverchko Tags: Chemistry, Biochemistry and Pharmacology Tools and Techniques Cool Tools/Techniques Cool Videos Medicines Science Snippet Source Type: blogs

A Longevity Industry Feature in Biopharma Dealmakers: Repair Biotechnologies, Deciduous Therapeutics, and More
In this study, a single treatment at the peak of disease resulted in the ablation of senescent cells in the lung and attenuation of key fibrotic and inflammatory markers, which ultimately resolved fibrosis. Deciduous Therapeutics has used computational assisted design to synthesise a suite of proprietary therapies that could be used in the clinic to re-activate tissue-resident iNKT cells. To date, the company's lead program has shown single-dose efficacy in resolving both metabolic and fibrotic diseases along with a favorable safety profile at doses significantly higher than the efficacious dose. (Source: Fight Aging!)
Source: Fight Aging! - December 4, 2023 Category: Research Authors: Reason Tags: Longevity Industry Source Type: blogs

Your Insulin of the Future Could Be " Made in China " if Big PBMs Have a Say in the Matter
Back on June 16, 2022, I published an article on LinkedIn entitled "How the Civica Insulin Announcement May Be Disruptive to the PBM Kickback Scheme" (see the article athttps://www.linkedin.com/pulse/how-civica-insulin-announcement-may-disruptive-pbm-scheme-strumello/ if you wish to read it) which predicted that a growing number of insulin biosimilars whose active pharmaceutical ingredients (API ' s) are cultured in offshore laboratories are forecast to hit the U.S. market in the next few years. According to the FDA and the individual companies whom I also follow on LinkedIn, the U.S. Food and Drug Administration (FDA) typ...
Source: Scott's Web Log - October 15, 2023 Category: Endocrinology Tags: 2023 Congress insulin insulin prices lawmakers PBM Pharmacy Benefit Managers Source Type: blogs

Fight Aging! Newsletter, October 9th 2023
Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe or unsubscribe from the newsletter, please visit: https://www.fightaging.org/newsletter/ Longevity Industry Consulting Services Reason, the founder of Fight Aging! and Repair Biotechnologies, offers strategic consulting services to investors, entrepreneurs, and others interested in the longevity industry and its complexities. To find out m...
Source: Fight Aging! - October 8, 2023 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

A Outsider's Popular Science View of the Longevity Industry and Academia
A brace of popular science articles on aging research were recently published at the Economist. Like many of these views from a distance written by journalists on the outside, peering into the field, one must assume that its existence is largely the result of the sizable investments made over the last two years into the development of therapies based on partial reprogramming. The Altos Labs funding in particular represented a meaningful fraction of all investment into biotech made that year. That tends to attract attention. From there, an investigator would notice an additional broad focus on cellular senescence, many comp...
Source: Fight Aging! - October 2, 2023 Category: Research Authors: Reason Tags: Healthy Life Extension Community Source Type: blogs